Drug-Device Combination Products Industry Research Report 2023
Highlights
The global Drug-Device Combination Products market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Drug-Device Combination Products is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Asia-Pacific market for Drug-Device Combination Products is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
The major global companies of Drug-Device Combination Products include GSK, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Boston Scientific, Abbott, Boehringer Ingelheim and Medtronic, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Drug-Device Combination Products in Hospital andClinic is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Drug-Coated Device, which accounted for % of the global market of Drug-Device Combination Products in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug-Device Combination Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug-Device Combination Products.
The Drug-Device Combination Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drug-Device Combination Products market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug-Device Combination Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Drug-Device Combination Products type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Drug-Device Combination Products are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Drug-Device Combination Products segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Drug-Device Combination Products market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Drug-Device Combination Products market.
Drug-Device Combination Products Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Drug-Device Combination Products market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug-Device Combination Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Drug-Device Combination Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Drug-Device Combination Products industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug-Device Combination Products.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug-Device Combination Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
The global Drug-Device Combination Products market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Drug-Device Combination Products is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Asia-Pacific market for Drug-Device Combination Products is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
The major global companies of Drug-Device Combination Products include GSK, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Boston Scientific, Abbott, Boehringer Ingelheim and Medtronic, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Drug-Device Combination Products in Hospital andClinic is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Drug-Coated Device, which accounted for % of the global market of Drug-Device Combination Products in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug-Device Combination Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug-Device Combination Products.
The Drug-Device Combination Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drug-Device Combination Products market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug-Device Combination Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- GSK
- Novo Nordisk
- Eli Lilly
- AstraZeneca
- Sanofi
- Boston Scientific
- Abbott
- Boehringer Ingelheim
- Medtronic
- Mylan
- 3M
- Hisamitsu
- Smith & Nephew
- Molnlycke
- Teleflex
- BD
- Lepu Medical
- MicroPort
- Terumo
- B. Braun
- Antares Pharma
Global markets are presented by Drug-Device Combination Products type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Drug-Device Combination Products are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Drug-Device Combination Products segment by Type
- Drug-Coated Device
- Prefilled Drug Delivery Systems
- Nebulizer and Inhaler
- Transdermal Delivery System
- Others
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Drug-Device Combination Products market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Drug-Device Combination Products market.
Drug-Device Combination Products Segment by Application
- Hospital andClinic
- Retail Pharmacies
- Other
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Drug-Device Combination Products market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug-Device Combination Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Drug-Device Combination Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Drug-Device Combination Products industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug-Device Combination Products.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug-Device Combination Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Drug-Device Combination Products by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Drug-Coated Device
1.2.3 Prefilled Drug Delivery Systems
1.2.4 Nebulizer and Inhaler
1.2.5 Transdermal Delivery System
1.2.6 Others
2.3 Drug-Device Combination Products by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Hospital andClinic
2.3.3 Retail Pharmacies
2.3.4 Other
2.4 Assumptions and Limitations
3 DRUG-DEVICE COMBINATION PRODUCTS BREAKDOWN DATA BY TYPE
3.1 Global Drug-Device Combination Products Historic Market Size by Type (2018-2023)
3.2 Global Drug-Device Combination Products Forecasted Market Size by Type (2023-2028)
4 DRUG-DEVICE COMBINATION PRODUCTS BREAKDOWN DATA BY APPLICATION
4.1 Global Drug-Device Combination Products Historic Market Size by Application (2018-2023)
4.2 Global Drug-Device Combination Products Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Drug-Device Combination Products Market Perspective (2018-2029)
5.2 Global Drug-Device Combination Products Growth Trends by Region
5.2.1 Global Drug-Device Combination Products Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Drug-Device Combination Products Historic Market Size by Region (2018-2023)
5.2.3 Drug-Device Combination Products Forecasted Market Size by Region (2024-2029)
5.3 Drug-Device Combination Products Market Dynamics
5.3.1 Drug-Device Combination Products Industry Trends
5.3.2 Drug-Device Combination Products Market Drivers
5.3.3 Drug-Device Combination Products Market Challenges
5.3.4 Drug-Device Combination Products Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Drug-Device Combination Products Players by Revenue
6.1.1 Global Top Drug-Device Combination Products Players by Revenue (2018-2023)
6.1.2 Global Drug-Device Combination Products Revenue Market Share by Players (2018-2023)
6.2 Global Drug-Device Combination Products Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Drug-Device Combination Products Head office and Area Served
6.4 Global Drug-Device Combination Products Players, Product Type & Application
6.5 Global Drug-Device Combination Products Players, Date of Enter into This Industry
6.6 Global Drug-Device Combination Products Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Drug-Device Combination Products Market Size (2018-2029)
7.2 North America Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Drug-Device Combination Products Market Size by Country (2018-2023)
7.4 North America Drug-Device Combination Products Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Drug-Device Combination Products Market Size (2018-2029)
8.2 Europe Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Drug-Device Combination Products Market Size by Country (2018-2023)
8.4 Europe Drug-Device Combination Products Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Drug-Device Combination Products Market Size (2018-2029)
9.2 Asia-Pacific Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Drug-Device Combination Products Market Size by Country (2018-2023)
9.4 Asia-Pacific Drug-Device Combination Products Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Drug-Device Combination Products Market Size (2018-2029)
10.2 Latin America Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Drug-Device Combination Products Market Size by Country (2018-2023)
10.4 Latin America Drug-Device Combination Products Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Drug-Device Combination Products Market Size (2018-2029)
11.2 Middle East & Africa Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Drug-Device Combination Products Market Size by Country (2018-2023)
11.4 Middle East & Africa Drug-Device Combination Products Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Drug-Device Combination Products Introduction
11.1.4 GSK Revenue in Drug-Device Combination Products Business (2017-2022)
11.1.5 GSK Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Detail
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Drug-Device Combination Products Introduction
11.2.4 Novo Nordisk Revenue in Drug-Device Combination Products Business (2017-2022)
11.2.5 Novo Nordisk Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Drug-Device Combination Products Introduction
11.3.4 Eli Lilly Revenue in Drug-Device Combination Products Business (2017-2022)
11.3.5 Eli Lilly Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Drug-Device Combination Products Introduction
11.4.4 AstraZeneca Revenue in Drug-Device Combination Products Business (2017-2022)
11.4.5 AstraZeneca Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Drug-Device Combination Products Introduction
11.5.4 Sanofi Revenue in Drug-Device Combination Products Business (2017-2022)
11.5.5 Sanofi Recent Development
11.6 Boston Scientific
11.6.1 Boston Scientific Company Detail
11.6.2 Boston Scientific Business Overview
11.6.3 Boston Scientific Drug-Device Combination Products Introduction
11.6.4 Boston Scientific Revenue in Drug-Device Combination Products Business (2017-2022)
11.6.5 Boston Scientific Recent Development
11.7 Abbott
11.7.1 Abbott Company Detail
11.7.2 Abbott Business Overview
11.7.3 Abbott Drug-Device Combination Products Introduction
11.7.4 Abbott Revenue in Drug-Device Combination Products Business (2017-2022)
11.7.5 Abbott Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Detail
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Drug-Device Combination Products Introduction
11.8.4 Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (2017-2022)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Medtronic
11.9.1 Medtronic Company Detail
11.9.2 Medtronic Business Overview
11.9.3 Medtronic Drug-Device Combination Products Introduction
11.9.4 Medtronic Revenue in Drug-Device Combination Products Business (2017-2022)
11.9.5 Medtronic Recent Development
11.10 Mylan
11.10.1 Mylan Company Detail
11.10.2 Mylan Business Overview
11.10.3 Mylan Drug-Device Combination Products Introduction
11.10.4 Mylan Revenue in Drug-Device Combination Products Business (2017-2022)
11.10.5 Mylan Recent Development
11.11 3M
11.11.1 3M Company Detail
11.11.2 3M Business Overview
11.11.3 3M Drug-Device Combination Products Introduction
11.11.4 3M Revenue in Drug-Device Combination Products Business (2017-2022)
11.11.5 3M Recent Development
11.12 Hisamitsu
11.12.1 Hisamitsu Company Detail
11.12.2 Hisamitsu Business Overview
11.12.3 Hisamitsu Drug-Device Combination Products Introduction
11.12.4 Hisamitsu Revenue in Drug-Device Combination Products Business (2017-2022)
11.12.5 Hisamitsu Recent Development
11.13 Smith & Nephew
11.13.1 Smith & Nephew Company Detail
11.13.2 Smith & Nephew Business Overview
11.13.3 Smith & Nephew Drug-Device Combination Products Introduction
11.13.4 Smith & Nephew Revenue in Drug-Device Combination Products Business (2017-2022)
11.13.5 Smith & Nephew Recent Development
11.14 Molnlycke
11.14.1 Molnlycke Company Detail
11.14.2 Molnlycke Business Overview
11.14.3 Molnlycke Drug-Device Combination Products Introduction
11.14.4 Molnlycke Revenue in Drug-Device Combination Products Business (2017-2022)
11.14.5 Molnlycke Recent Development
11.15 Teleflex
11.15.1 Teleflex Company Detail
11.15.2 Teleflex Business Overview
11.15.3 Teleflex Drug-Device Combination Products Introduction
11.15.4 Teleflex Revenue in Drug-Device Combination Products Business (2017-2022)
11.15.5 Teleflex Recent Development
11.16 BD
11.16.1 BD Company Detail
11.16.2 BD Business Overview
11.16.3 BD Drug-Device Combination Products Introduction
11.16.4 BD Revenue in Drug-Device Combination Products Business (2017-2022)
11.16.5 BD Recent Development
11.17 Lepu Medical
11.17.1 Lepu Medical Company Detail
11.17.2 Lepu Medical Business Overview
11.17.3 Lepu Medical Drug-Device Combination Products Introduction
11.17.4 Lepu Medical Revenue in Drug-Device Combination Products Business (2017-2022)
11.17.5 Lepu Medical Recent Development
11.18 MicroPort
11.18.1 MicroPort Company Detail
11.18.2 MicroPort Business Overview
11.18.3 MicroPort Drug-Device Combination Products Introduction
11.18.4 MicroPort Revenue in Drug-Device Combination Products Business (2017-2022)
11.18.5 MicroPort Recent Development
11.19 Terumo
11.19.1 Terumo Company Detail
11.19.2 Terumo Business Overview
11.19.3 Terumo Drug-Device Combination Products Introduction
11.19.4 Terumo Revenue in Drug-Device Combination Products Business (2017-2022)
11.19.5 Terumo Recent Development
11.20 B. Braun
11.20.1 B. Braun Company Detail
11.20.2 B. Braun Business Overview
11.20.3 B. Braun Drug-Device Combination Products Introduction
11.20.4 B. Braun Revenue in Drug-Device Combination Products Business (2017-2022)
11.20.5 B. Braun Recent Development
11.21 Antares Pharma
11.21.1 Antares Pharma Company Detail
11.21.2 Antares Pharma Business Overview
11.21.3 Antares Pharma Drug-Device Combination Products Introduction
11.21.4 Antares Pharma Revenue in Drug-Device Combination Products Business (2017-2022)
11.21.5 Antares Pharma Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Drug-Device Combination Products by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Drug-Coated Device
1.2.3 Prefilled Drug Delivery Systems
1.2.4 Nebulizer and Inhaler
1.2.5 Transdermal Delivery System
1.2.6 Others
2.3 Drug-Device Combination Products by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Hospital andClinic
2.3.3 Retail Pharmacies
2.3.4 Other
2.4 Assumptions and Limitations
3 DRUG-DEVICE COMBINATION PRODUCTS BREAKDOWN DATA BY TYPE
3.1 Global Drug-Device Combination Products Historic Market Size by Type (2018-2023)
3.2 Global Drug-Device Combination Products Forecasted Market Size by Type (2023-2028)
4 DRUG-DEVICE COMBINATION PRODUCTS BREAKDOWN DATA BY APPLICATION
4.1 Global Drug-Device Combination Products Historic Market Size by Application (2018-2023)
4.2 Global Drug-Device Combination Products Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Drug-Device Combination Products Market Perspective (2018-2029)
5.2 Global Drug-Device Combination Products Growth Trends by Region
5.2.1 Global Drug-Device Combination Products Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Drug-Device Combination Products Historic Market Size by Region (2018-2023)
5.2.3 Drug-Device Combination Products Forecasted Market Size by Region (2024-2029)
5.3 Drug-Device Combination Products Market Dynamics
5.3.1 Drug-Device Combination Products Industry Trends
5.3.2 Drug-Device Combination Products Market Drivers
5.3.3 Drug-Device Combination Products Market Challenges
5.3.4 Drug-Device Combination Products Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Drug-Device Combination Products Players by Revenue
6.1.1 Global Top Drug-Device Combination Products Players by Revenue (2018-2023)
6.1.2 Global Drug-Device Combination Products Revenue Market Share by Players (2018-2023)
6.2 Global Drug-Device Combination Products Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Drug-Device Combination Products Head office and Area Served
6.4 Global Drug-Device Combination Products Players, Product Type & Application
6.5 Global Drug-Device Combination Products Players, Date of Enter into This Industry
6.6 Global Drug-Device Combination Products Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Drug-Device Combination Products Market Size (2018-2029)
7.2 North America Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Drug-Device Combination Products Market Size by Country (2018-2023)
7.4 North America Drug-Device Combination Products Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Drug-Device Combination Products Market Size (2018-2029)
8.2 Europe Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Drug-Device Combination Products Market Size by Country (2018-2023)
8.4 Europe Drug-Device Combination Products Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Drug-Device Combination Products Market Size (2018-2029)
9.2 Asia-Pacific Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Drug-Device Combination Products Market Size by Country (2018-2023)
9.4 Asia-Pacific Drug-Device Combination Products Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Drug-Device Combination Products Market Size (2018-2029)
10.2 Latin America Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Drug-Device Combination Products Market Size by Country (2018-2023)
10.4 Latin America Drug-Device Combination Products Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Drug-Device Combination Products Market Size (2018-2029)
11.2 Middle East & Africa Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Drug-Device Combination Products Market Size by Country (2018-2023)
11.4 Middle East & Africa Drug-Device Combination Products Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Drug-Device Combination Products Introduction
11.1.4 GSK Revenue in Drug-Device Combination Products Business (2017-2022)
11.1.5 GSK Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Detail
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Drug-Device Combination Products Introduction
11.2.4 Novo Nordisk Revenue in Drug-Device Combination Products Business (2017-2022)
11.2.5 Novo Nordisk Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Drug-Device Combination Products Introduction
11.3.4 Eli Lilly Revenue in Drug-Device Combination Products Business (2017-2022)
11.3.5 Eli Lilly Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Drug-Device Combination Products Introduction
11.4.4 AstraZeneca Revenue in Drug-Device Combination Products Business (2017-2022)
11.4.5 AstraZeneca Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Drug-Device Combination Products Introduction
11.5.4 Sanofi Revenue in Drug-Device Combination Products Business (2017-2022)
11.5.5 Sanofi Recent Development
11.6 Boston Scientific
11.6.1 Boston Scientific Company Detail
11.6.2 Boston Scientific Business Overview
11.6.3 Boston Scientific Drug-Device Combination Products Introduction
11.6.4 Boston Scientific Revenue in Drug-Device Combination Products Business (2017-2022)
11.6.5 Boston Scientific Recent Development
11.7 Abbott
11.7.1 Abbott Company Detail
11.7.2 Abbott Business Overview
11.7.3 Abbott Drug-Device Combination Products Introduction
11.7.4 Abbott Revenue in Drug-Device Combination Products Business (2017-2022)
11.7.5 Abbott Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Detail
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Drug-Device Combination Products Introduction
11.8.4 Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (2017-2022)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Medtronic
11.9.1 Medtronic Company Detail
11.9.2 Medtronic Business Overview
11.9.3 Medtronic Drug-Device Combination Products Introduction
11.9.4 Medtronic Revenue in Drug-Device Combination Products Business (2017-2022)
11.9.5 Medtronic Recent Development
11.10 Mylan
11.10.1 Mylan Company Detail
11.10.2 Mylan Business Overview
11.10.3 Mylan Drug-Device Combination Products Introduction
11.10.4 Mylan Revenue in Drug-Device Combination Products Business (2017-2022)
11.10.5 Mylan Recent Development
11.11 3M
11.11.1 3M Company Detail
11.11.2 3M Business Overview
11.11.3 3M Drug-Device Combination Products Introduction
11.11.4 3M Revenue in Drug-Device Combination Products Business (2017-2022)
11.11.5 3M Recent Development
11.12 Hisamitsu
11.12.1 Hisamitsu Company Detail
11.12.2 Hisamitsu Business Overview
11.12.3 Hisamitsu Drug-Device Combination Products Introduction
11.12.4 Hisamitsu Revenue in Drug-Device Combination Products Business (2017-2022)
11.12.5 Hisamitsu Recent Development
11.13 Smith & Nephew
11.13.1 Smith & Nephew Company Detail
11.13.2 Smith & Nephew Business Overview
11.13.3 Smith & Nephew Drug-Device Combination Products Introduction
11.13.4 Smith & Nephew Revenue in Drug-Device Combination Products Business (2017-2022)
11.13.5 Smith & Nephew Recent Development
11.14 Molnlycke
11.14.1 Molnlycke Company Detail
11.14.2 Molnlycke Business Overview
11.14.3 Molnlycke Drug-Device Combination Products Introduction
11.14.4 Molnlycke Revenue in Drug-Device Combination Products Business (2017-2022)
11.14.5 Molnlycke Recent Development
11.15 Teleflex
11.15.1 Teleflex Company Detail
11.15.2 Teleflex Business Overview
11.15.3 Teleflex Drug-Device Combination Products Introduction
11.15.4 Teleflex Revenue in Drug-Device Combination Products Business (2017-2022)
11.15.5 Teleflex Recent Development
11.16 BD
11.16.1 BD Company Detail
11.16.2 BD Business Overview
11.16.3 BD Drug-Device Combination Products Introduction
11.16.4 BD Revenue in Drug-Device Combination Products Business (2017-2022)
11.16.5 BD Recent Development
11.17 Lepu Medical
11.17.1 Lepu Medical Company Detail
11.17.2 Lepu Medical Business Overview
11.17.3 Lepu Medical Drug-Device Combination Products Introduction
11.17.4 Lepu Medical Revenue in Drug-Device Combination Products Business (2017-2022)
11.17.5 Lepu Medical Recent Development
11.18 MicroPort
11.18.1 MicroPort Company Detail
11.18.2 MicroPort Business Overview
11.18.3 MicroPort Drug-Device Combination Products Introduction
11.18.4 MicroPort Revenue in Drug-Device Combination Products Business (2017-2022)
11.18.5 MicroPort Recent Development
11.19 Terumo
11.19.1 Terumo Company Detail
11.19.2 Terumo Business Overview
11.19.3 Terumo Drug-Device Combination Products Introduction
11.19.4 Terumo Revenue in Drug-Device Combination Products Business (2017-2022)
11.19.5 Terumo Recent Development
11.20 B. Braun
11.20.1 B. Braun Company Detail
11.20.2 B. Braun Business Overview
11.20.3 B. Braun Drug-Device Combination Products Introduction
11.20.4 B. Braun Revenue in Drug-Device Combination Products Business (2017-2022)
11.20.5 B. Braun Recent Development
11.21 Antares Pharma
11.21.1 Antares Pharma Company Detail
11.21.2 Antares Pharma Business Overview
11.21.3 Antares Pharma Drug-Device Combination Products Introduction
11.21.4 Antares Pharma Revenue in Drug-Device Combination Products Business (2017-2022)
11.21.5 Antares Pharma Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Drug-Device Combination Products Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Drug-Device Combination Products Revenue Market Share by Type (2018-2023)
Table 7. Global Drug-Device Combination Products Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Drug-Device Combination Products Revenue Market Share by Type (2024-2029)
Table 9. Global Drug-Device Combination Products Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Drug-Device Combination Products Revenue Market Share by Application (2018-2023)
Table 11. Global Drug-Device Combination Products Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Drug-Device Combination Products Revenue Market Share by Application (2024-2029)
Table 13. Global Drug-Device Combination Products Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Drug-Device Combination Products Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Drug-Device Combination Products Market Share by Region (2018-2023)
Table 16. Global Drug-Device Combination Products Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Drug-Device Combination Products Market Share by Region (2024-2029)
Table 18. Drug-Device Combination Products Market Trends
Table 19. Drug-Device Combination Products Market Drivers
Table 20. Drug-Device Combination Products Market Challenges
Table 21. Drug-Device Combination Products Market Restraints
Table 22. Global Top Drug-Device Combination Products Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Drug-Device Combination Products Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Drug-Device Combination Products Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Drug-Device Combination Products, Headquarters and Area Served
Table 26. Global Drug-Device Combination Products Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Drug-Device Combination Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Drug-Device Combination Products Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Drug-Device Combination Products Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Drug-Device Combination Products Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Drug-Device Combination Products Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Drug-Device Combination Products Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Drug-Device Combination Products Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Drug-Device Combination Products Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Drug-Device Combination Products Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Drug-Device Combination Products Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Drug-Device Combination Products Market Size by Country (2024-2029) & (US$ Million)
Table 45. GSK Company Detail
Table 46. GSK Business Overview
Table 47. GSK Drug-Device Combination Products Product
Table 48. GSK Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 49. GSK Recent Development
Table 50. Novo Nordisk Company Detail
Table 51. Novo Nordisk Business Overview
Table 52. Novo Nordisk Drug-Device Combination Products Product
Table 53. Novo Nordisk Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 54. Novo Nordisk Recent Development
Table 55. Eli Lilly Company Detail
Table 56. Eli Lilly Business Overview
Table 57. Eli Lilly Drug-Device Combination Products Product
Table 58. Eli Lilly Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 59. Eli Lilly Recent Development
Table 60. AstraZeneca Company Detail
Table 61. AstraZeneca Business Overview
Table 62. AstraZeneca Drug-Device Combination Products Product
Table 63. AstraZeneca Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 64. AstraZeneca Recent Development
Table 65. Sanofi Company Detail
Table 66. Sanofi Business Overview
Table 67. Sanofi Drug-Device Combination Products Product
Table 68. Sanofi Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 69. Sanofi Recent Development
Table 70. Boston Scientific Company Detail
Table 71. Boston Scientific Business Overview
Table 72. Boston Scientific Drug-Device Combination Products Product
Table 73. Boston Scientific Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 74. Boston Scientific Recent Development
Table 75. Abbott Company Detail
Table 76. Abbott Business Overview
Table 77. Abbott Drug-Device Combination Products Product
Table 78. Abbott Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 79. Abbott Recent Development
Table 80. Boehringer Ingelheim Company Detail
Table 81. Boehringer Ingelheim Business Overview
Table 82. Boehringer Ingelheim Drug-Device Combination Products Product
Table 83. Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 84. Boehringer Ingelheim Recent Development
Table 85. Medtronic Company Detail
Table 86. Medtronic Business Overview
Table 87. Medtronic Drug-Device Combination Products Product
Table 88. Medtronic Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 89. Medtronic Recent Development
Table 90. Mylan Company Detail
Table 91. Mylan Business Overview
Table 92. Mylan Drug-Device Combination Products Product
Table 93. Mylan Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 94. Mylan Recent Development
Table 95. 3M Company Detail
Table 96. 3M Business Overview
Table 97. 3M Drug-Device Combination ProductsProduct
Table 98. 3M Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 99. 3M Recent Development
Table 100. Hisamitsu Company Detail
Table 101. Hisamitsu Business Overview
Table 102. Hisamitsu Drug-Device Combination ProductsProduct
Table 103. Hisamitsu Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 104. Hisamitsu Recent Development
Table 105. Smith & Nephew Company Detail
Table 106. Smith & Nephew Business Overview
Table 107. Smith & Nephew Drug-Device Combination ProductsProduct
Table 108. Smith & Nephew Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 109. Smith & Nephew Recent Development
Table 110. Molnlycke Company Detail
Table 111. Molnlycke Business Overview
Table 112. Molnlycke Drug-Device Combination ProductsProduct
Table 113. Molnlycke Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 114. Molnlycke Recent Development
Table 115. Teleflex Company Detail
Table 116. Teleflex Business Overview
Table 117. Teleflex Drug-Device Combination ProductsProduct
Table 118. Teleflex Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 119. Teleflex Recent Development
Table 120. BD Company Detail
Table 121. BD Business Overview
Table 122. BD Drug-Device Combination ProductsProduct
Table 123. BD Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 124. BD Recent Development
Table 125. Lepu Medical Company Detail
Table 126. Lepu Medical Business Overview
Table 127. Lepu Medical Drug-Device Combination ProductsProduct
Table 128. Lepu Medical Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 129. Lepu Medical Recent Development
Table 130. MicroPort Company Detail
Table 131. MicroPort Business Overview
Table 132. MicroPort Drug-Device Combination ProductsProduct
Table 133. MicroPort Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 134. MicroPort Recent Development
Table 135. Terumo Company Detail
Table 136. Terumo Business Overview
Table 137. Terumo Drug-Device Combination ProductsProduct
Table 138. Terumo Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 139. Terumo Recent Development
Table 140. B. Braun Company Detail
Table 141. B. Braun Business Overview
Table 142. B. Braun Drug-Device Combination ProductsProduct
Table 143. B. Braun Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 144. B. Braun Recent Development
Table 145. Antares Pharma Company Detail
Table 146. Antares Pharma Business Overview
Table 147. Antares Pharma Drug-Device Combination ProductsProduct
Table 148. Antares Pharma Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 149. Antares Pharma Recent Development
Table 150. GSK Company Information
Table 151. GSK Business Overview
Table 152. GSK Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 153. GSK Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 154. GSK Recent Development
Table 155. Novo Nordisk Company Information
Table 156. Novo Nordisk Business Overview
Table 157. Novo Nordisk Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 158. Novo Nordisk Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 159. Novo Nordisk Recent Development
Table 160. Eli Lilly Company Information
Table 161. Eli Lilly Business Overview
Table 162. Eli Lilly Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 163. Eli Lilly Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 164. Eli Lilly Recent Development
Table 165. AstraZeneca Company Information
Table 166. AstraZeneca Business Overview
Table 167. AstraZeneca Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 168. AstraZeneca Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 169. AstraZeneca Recent Development
Table 170. Sanofi Company Information
Table 171. Sanofi Business Overview
Table 172. Sanofi Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 173. Sanofi Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 174. Sanofi Recent Development
Table 175. Boston Scientific Company Information
Table 176. Boston Scientific Business Overview
Table 177. Boston Scientific Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 178. Boston Scientific Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 179. Boston Scientific Recent Development
Table 180. Abbott Company Information
Table 181. Abbott Business Overview
Table 182. Abbott Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 183. Abbott Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 184. Abbott Recent Development
Table 185. Boehringer Ingelheim Company Information
Table 186. Boehringer Ingelheim Business Overview
Table 187. Boehringer Ingelheim Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 188. Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 189. Boehringer Ingelheim Recent Development
Table 190. Medtronic Company Information
Table 191. Medtronic Business Overview
Table 192. Medtronic Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 193. Medtronic Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 194. Medtronic Recent Development
Table 195. Mylan Company Information
Table 196. Mylan Business Overview
Table 197. Mylan Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 198. Mylan Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 199. Mylan Recent Development
Table 200. 3M Company Information
Table 201. 3M Business Overview
Table 202. 3M Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 203. 3M Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 204. 3M Recent Development
Table 205. Hisamitsu Company Information
Table 206. Hisamitsu Business Overview
Table 207. Hisamitsu Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 208. Hisamitsu Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 209. Hisamitsu Recent Development
Table 210. Smith & Nephew Company Information
Table 211. Smith & Nephew Business Overview
Table 212. Smith & Nephew Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 213. Smith & Nephew Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 214. Smith & Nephew Recent Development
Table 215. Molnlycke Company Information
Table 216. Molnlycke Business Overview
Table 217. Molnlycke Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 218. Molnlycke Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 219. Molnlycke Recent Development
Table 220. Teleflex Company Information
Table 221. Teleflex Business Overview
Table 222. Teleflex Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 223. Teleflex Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 224. Teleflex Recent Development
Table 225. BD Company Information
Table 226. BD Business Overview
Table 227. BD Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 228. BD Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 229. BD Recent Development
Table 230. Lepu Medical Company Information
Table 231. Lepu Medical Business Overview
Table 232. Lepu Medical Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 233. Lepu Medical Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 234. Lepu Medical Recent Development
Table 235. MicroPort Company Information
Table 236. MicroPort Business Overview
Table 237. MicroPort Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 238. MicroPort Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 239. MicroPort Recent Development
Table 240. Terumo Company Information
Table 241. Terumo Business Overview
Table 242. Terumo Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 243. Terumo Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 244. Terumo Recent Development
Table 245. B. Braun Company Information
Table 246. B. Braun Business Overview
Table 247. B. Braun Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 248. B. Braun Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 249. B. Braun Recent Development
Table 250. Antares Pharma Company Information
Table 251. Antares Pharma Business Overview
Table 252. Antares Pharma Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 253. Antares Pharma Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 254. Antares Pharma Recent Development
Table 255. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Drug-Device Combination Products Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Drug-Device Combination Products Revenue Market Share by Type (2018-2023)
Table 7. Global Drug-Device Combination Products Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Drug-Device Combination Products Revenue Market Share by Type (2024-2029)
Table 9. Global Drug-Device Combination Products Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Drug-Device Combination Products Revenue Market Share by Application (2018-2023)
Table 11. Global Drug-Device Combination Products Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Drug-Device Combination Products Revenue Market Share by Application (2024-2029)
Table 13. Global Drug-Device Combination Products Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Drug-Device Combination Products Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Drug-Device Combination Products Market Share by Region (2018-2023)
Table 16. Global Drug-Device Combination Products Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Drug-Device Combination Products Market Share by Region (2024-2029)
Table 18. Drug-Device Combination Products Market Trends
Table 19. Drug-Device Combination Products Market Drivers
Table 20. Drug-Device Combination Products Market Challenges
Table 21. Drug-Device Combination Products Market Restraints
Table 22. Global Top Drug-Device Combination Products Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Drug-Device Combination Products Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Drug-Device Combination Products Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Drug-Device Combination Products, Headquarters and Area Served
Table 26. Global Drug-Device Combination Products Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Drug-Device Combination Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Drug-Device Combination Products Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Drug-Device Combination Products Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Drug-Device Combination Products Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Drug-Device Combination Products Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Drug-Device Combination Products Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Drug-Device Combination Products Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Drug-Device Combination Products Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Drug-Device Combination Products Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Drug-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Drug-Device Combination Products Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Drug-Device Combination Products Market Size by Country (2024-2029) & (US$ Million)
Table 45. GSK Company Detail
Table 46. GSK Business Overview
Table 47. GSK Drug-Device Combination Products Product
Table 48. GSK Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 49. GSK Recent Development
Table 50. Novo Nordisk Company Detail
Table 51. Novo Nordisk Business Overview
Table 52. Novo Nordisk Drug-Device Combination Products Product
Table 53. Novo Nordisk Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 54. Novo Nordisk Recent Development
Table 55. Eli Lilly Company Detail
Table 56. Eli Lilly Business Overview
Table 57. Eli Lilly Drug-Device Combination Products Product
Table 58. Eli Lilly Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 59. Eli Lilly Recent Development
Table 60. AstraZeneca Company Detail
Table 61. AstraZeneca Business Overview
Table 62. AstraZeneca Drug-Device Combination Products Product
Table 63. AstraZeneca Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 64. AstraZeneca Recent Development
Table 65. Sanofi Company Detail
Table 66. Sanofi Business Overview
Table 67. Sanofi Drug-Device Combination Products Product
Table 68. Sanofi Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 69. Sanofi Recent Development
Table 70. Boston Scientific Company Detail
Table 71. Boston Scientific Business Overview
Table 72. Boston Scientific Drug-Device Combination Products Product
Table 73. Boston Scientific Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 74. Boston Scientific Recent Development
Table 75. Abbott Company Detail
Table 76. Abbott Business Overview
Table 77. Abbott Drug-Device Combination Products Product
Table 78. Abbott Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 79. Abbott Recent Development
Table 80. Boehringer Ingelheim Company Detail
Table 81. Boehringer Ingelheim Business Overview
Table 82. Boehringer Ingelheim Drug-Device Combination Products Product
Table 83. Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 84. Boehringer Ingelheim Recent Development
Table 85. Medtronic Company Detail
Table 86. Medtronic Business Overview
Table 87. Medtronic Drug-Device Combination Products Product
Table 88. Medtronic Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 89. Medtronic Recent Development
Table 90. Mylan Company Detail
Table 91. Mylan Business Overview
Table 92. Mylan Drug-Device Combination Products Product
Table 93. Mylan Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 94. Mylan Recent Development
Table 95. 3M Company Detail
Table 96. 3M Business Overview
Table 97. 3M Drug-Device Combination ProductsProduct
Table 98. 3M Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 99. 3M Recent Development
Table 100. Hisamitsu Company Detail
Table 101. Hisamitsu Business Overview
Table 102. Hisamitsu Drug-Device Combination ProductsProduct
Table 103. Hisamitsu Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 104. Hisamitsu Recent Development
Table 105. Smith & Nephew Company Detail
Table 106. Smith & Nephew Business Overview
Table 107. Smith & Nephew Drug-Device Combination ProductsProduct
Table 108. Smith & Nephew Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 109. Smith & Nephew Recent Development
Table 110. Molnlycke Company Detail
Table 111. Molnlycke Business Overview
Table 112. Molnlycke Drug-Device Combination ProductsProduct
Table 113. Molnlycke Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 114. Molnlycke Recent Development
Table 115. Teleflex Company Detail
Table 116. Teleflex Business Overview
Table 117. Teleflex Drug-Device Combination ProductsProduct
Table 118. Teleflex Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 119. Teleflex Recent Development
Table 120. BD Company Detail
Table 121. BD Business Overview
Table 122. BD Drug-Device Combination ProductsProduct
Table 123. BD Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 124. BD Recent Development
Table 125. Lepu Medical Company Detail
Table 126. Lepu Medical Business Overview
Table 127. Lepu Medical Drug-Device Combination ProductsProduct
Table 128. Lepu Medical Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 129. Lepu Medical Recent Development
Table 130. MicroPort Company Detail
Table 131. MicroPort Business Overview
Table 132. MicroPort Drug-Device Combination ProductsProduct
Table 133. MicroPort Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 134. MicroPort Recent Development
Table 135. Terumo Company Detail
Table 136. Terumo Business Overview
Table 137. Terumo Drug-Device Combination ProductsProduct
Table 138. Terumo Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 139. Terumo Recent Development
Table 140. B. Braun Company Detail
Table 141. B. Braun Business Overview
Table 142. B. Braun Drug-Device Combination ProductsProduct
Table 143. B. Braun Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 144. B. Braun Recent Development
Table 145. Antares Pharma Company Detail
Table 146. Antares Pharma Business Overview
Table 147. Antares Pharma Drug-Device Combination ProductsProduct
Table 148. Antares Pharma Revenue in Drug-Device Combination Products Business (2017-2022) & (US$ Million)
Table 149. Antares Pharma Recent Development
Table 150. GSK Company Information
Table 151. GSK Business Overview
Table 152. GSK Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 153. GSK Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 154. GSK Recent Development
Table 155. Novo Nordisk Company Information
Table 156. Novo Nordisk Business Overview
Table 157. Novo Nordisk Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 158. Novo Nordisk Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 159. Novo Nordisk Recent Development
Table 160. Eli Lilly Company Information
Table 161. Eli Lilly Business Overview
Table 162. Eli Lilly Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 163. Eli Lilly Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 164. Eli Lilly Recent Development
Table 165. AstraZeneca Company Information
Table 166. AstraZeneca Business Overview
Table 167. AstraZeneca Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 168. AstraZeneca Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 169. AstraZeneca Recent Development
Table 170. Sanofi Company Information
Table 171. Sanofi Business Overview
Table 172. Sanofi Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 173. Sanofi Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 174. Sanofi Recent Development
Table 175. Boston Scientific Company Information
Table 176. Boston Scientific Business Overview
Table 177. Boston Scientific Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 178. Boston Scientific Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 179. Boston Scientific Recent Development
Table 180. Abbott Company Information
Table 181. Abbott Business Overview
Table 182. Abbott Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 183. Abbott Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 184. Abbott Recent Development
Table 185. Boehringer Ingelheim Company Information
Table 186. Boehringer Ingelheim Business Overview
Table 187. Boehringer Ingelheim Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 188. Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 189. Boehringer Ingelheim Recent Development
Table 190. Medtronic Company Information
Table 191. Medtronic Business Overview
Table 192. Medtronic Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 193. Medtronic Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 194. Medtronic Recent Development
Table 195. Mylan Company Information
Table 196. Mylan Business Overview
Table 197. Mylan Drug-Device Combination Products Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 198. Mylan Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 199. Mylan Recent Development
Table 200. 3M Company Information
Table 201. 3M Business Overview
Table 202. 3M Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 203. 3M Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 204. 3M Recent Development
Table 205. Hisamitsu Company Information
Table 206. Hisamitsu Business Overview
Table 207. Hisamitsu Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 208. Hisamitsu Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 209. Hisamitsu Recent Development
Table 210. Smith & Nephew Company Information
Table 211. Smith & Nephew Business Overview
Table 212. Smith & Nephew Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 213. Smith & Nephew Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 214. Smith & Nephew Recent Development
Table 215. Molnlycke Company Information
Table 216. Molnlycke Business Overview
Table 217. Molnlycke Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 218. Molnlycke Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 219. Molnlycke Recent Development
Table 220. Teleflex Company Information
Table 221. Teleflex Business Overview
Table 222. Teleflex Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 223. Teleflex Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 224. Teleflex Recent Development
Table 225. BD Company Information
Table 226. BD Business Overview
Table 227. BD Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 228. BD Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 229. BD Recent Development
Table 230. Lepu Medical Company Information
Table 231. Lepu Medical Business Overview
Table 232. Lepu Medical Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 233. Lepu Medical Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 234. Lepu Medical Recent Development
Table 235. MicroPort Company Information
Table 236. MicroPort Business Overview
Table 237. MicroPort Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 238. MicroPort Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 239. MicroPort Recent Development
Table 240. Terumo Company Information
Table 241. Terumo Business Overview
Table 242. Terumo Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 243. Terumo Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 244. Terumo Recent Development
Table 245. B. Braun Company Information
Table 246. B. Braun Business Overview
Table 247. B. Braun Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 248. B. Braun Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 249. B. Braun Recent Development
Table 250. Antares Pharma Company Information
Table 251. Antares Pharma Business Overview
Table 252. Antares Pharma Drug-Device Combination ProductsRevenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million)
Table 253. Antares Pharma Revenue in Drug-Device Combination Products Business (2018-2023) & (US$ Million) Portfolio
Table 254. Antares Pharma Recent Development
Table 255. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Drug-Device Combination Products Product Picture
Figure 5. Global Drug-Device Combination Products Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Drug-Device Combination Products Market Share by Type: 2022 VS 2029
Figure 7. Drug-Coated Device Product Picture
Figure 8. Prefilled Drug Delivery Systems Product Picture
Figure 9. Nebulizer and Inhaler Product Picture
Figure 10. Transdermal Delivery System Product Picture
Figure 11. Others Product Picture
Figure 12. Global Drug-Device Combination Products Market Size by Application (2023-2029) & (US$ Million)
Figure 13. Global Drug-Device Combination Products Market Share by Application: 2022 VS 2029
Figure 14. Hospital andClinic Product Picture
Figure 15. Retail Pharmacies Product Picture
Figure 16. Other Product Picture
Figure 17. Global Drug-Device Combination Products Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Drug-Device Combination Products Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Drug-Device Combination Products Market Share by Region: 2022 VS 2029
Figure 20. Global Drug-Device Combination Products Market Share by Players in 2022
Figure 21. Global Drug-Device Combination Products Players, Date of Enter into This Industry
Figure 22. Global Top 5 and 10 Drug-Device Combination Products Players Market Share by Revenue in 2022
Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. North America Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. North America Drug-Device Combination Products Market Share by Country (2018-2029)
Figure 26. United States Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Canada Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Drug-Device Combination Products Market Share by Country (2018-2029)
Figure 30. Germany Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Asia-Pacific Drug-Device Combination Products Market Share by Country (2018-2029)
Figure 38. China Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Japan Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. India Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Australia Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Latin America Drug-Device Combination Products Market Share by Country (2018-2029)
Figure 46. Mexico Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Brazil Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Drug-Device Combination Products Market Share by Country (2018-2029)
Figure 50. Turkey Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. UAE Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. GSK Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 54. Novo Nordisk Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 55. Eli Lilly Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 56. AstraZeneca Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 57. Sanofi Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 58. Boston Scientific Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 59. Abbott Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 60. Boehringer Ingelheim Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 61. Medtronic Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 62. Mylan Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 63. 3M Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 64. Hisamitsu Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 65. Smith & Nephew Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 66. Molnlycke Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 67. Teleflex Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 68. BD Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 69. Lepu Medical Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 70. MicroPort Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 71. Terumo Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 72. B. Braun Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 73. Antares Pharma Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Drug-Device Combination Products Product Picture
Figure 5. Global Drug-Device Combination Products Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Drug-Device Combination Products Market Share by Type: 2022 VS 2029
Figure 7. Drug-Coated Device Product Picture
Figure 8. Prefilled Drug Delivery Systems Product Picture
Figure 9. Nebulizer and Inhaler Product Picture
Figure 10. Transdermal Delivery System Product Picture
Figure 11. Others Product Picture
Figure 12. Global Drug-Device Combination Products Market Size by Application (2023-2029) & (US$ Million)
Figure 13. Global Drug-Device Combination Products Market Share by Application: 2022 VS 2029
Figure 14. Hospital andClinic Product Picture
Figure 15. Retail Pharmacies Product Picture
Figure 16. Other Product Picture
Figure 17. Global Drug-Device Combination Products Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Drug-Device Combination Products Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Drug-Device Combination Products Market Share by Region: 2022 VS 2029
Figure 20. Global Drug-Device Combination Products Market Share by Players in 2022
Figure 21. Global Drug-Device Combination Products Players, Date of Enter into This Industry
Figure 22. Global Top 5 and 10 Drug-Device Combination Products Players Market Share by Revenue in 2022
Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. North America Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. North America Drug-Device Combination Products Market Share by Country (2018-2029)
Figure 26. United States Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Canada Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Drug-Device Combination Products Market Share by Country (2018-2029)
Figure 30. Germany Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Asia-Pacific Drug-Device Combination Products Market Share by Country (2018-2029)
Figure 38. China Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Japan Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. India Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Australia Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Latin America Drug-Device Combination Products Market Share by Country (2018-2029)
Figure 46. Mexico Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Brazil Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Drug-Device Combination Products Market Share by Country (2018-2029)
Figure 50. Turkey Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. UAE Drug-Device Combination Products Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. GSK Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 54. Novo Nordisk Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 55. Eli Lilly Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 56. AstraZeneca Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 57. Sanofi Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 58. Boston Scientific Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 59. Abbott Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 60. Boehringer Ingelheim Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 61. Medtronic Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 62. Mylan Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 63. 3M Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 64. Hisamitsu Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 65. Smith & Nephew Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 66. Molnlycke Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 67. Teleflex Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 68. BD Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 69. Lepu Medical Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 70. MicroPort Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 71. Terumo Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 72. B. Braun Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
Figure 73. Antares Pharma Revenue Growth Rate in Drug-Device Combination Products Business (2018-2023)
